Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study

@DrGRuralMD I think SGLT have potential to fill the role of becoming first line treatment, they suffer from lack of data in terms of safety and non-inferiority trials. I’ll link a study you probably didn’t read in med school. 🙃 Chen, TH., Li, YR., Chen, S

RT @kamleshkhunti: In T2DM, SGLT2i as first-line treatment associated with ⬇️ heart failure hospitalisation, acute coronary syndrome, and a…

RT @juanmarcosgg: Estudio que demuestra el tratamiento con SGLT2i cómo 1ª línea de tratamiento en diabetes M. tipo 2

https://t.co/Mok7ZwNT56